中国药物应用与监测
中國藥物應用與鑑測
중국약물응용여감측
CHINESE JOURNAL OF DRUG APPLICATION AND MONITORING
2013年
6期
315-317
,共3页
唐丽霞%周曙华%江雪红%蒋国华
唐麗霞%週曙華%江雪紅%蔣國華
당려하%주서화%강설홍%장국화
慢性阻塞性肺疾病急性加重期%临床药师%药学监护
慢性阻塞性肺疾病急性加重期%臨床藥師%藥學鑑護
만성조새성폐질병급성가중기%림상약사%약학감호
Acute exacerbation of chronic obstructive pulmonary diseases%Clinical pharmacist%Pharmaceutical care
1例89岁女性患者,因间断咳嗽、咳痰、胸闷、气喘10年,加重5 d入院,诊断为慢性阻塞性肺疾病急性加重期、慢性肺源性心脏病、慢性Ⅱ型呼吸衰竭等。入院后先后给予头孢他啶、头孢哌酮舒巴坦钠、亚胺培南西司他丁钠、替考拉宁、氟康唑、哌拉西林他唑巴坦抗感染;多索茶碱静滴联合异丙托溴铵、布地奈德雾化吸入平喘;氨溴索注射液祛痰;利尿剂改善心功能等治疗。治疗期间,结合患者的病情及相关检查,建议使用亚胺培南西司他丁钠和替考拉宁,并调整替考拉宁及利尿药的用量,重点监测头孢哌酮舒巴坦钠、亚胺培南西司他丁钠、替考拉宁的不良反应,定期监测血电解质,对患者进行用药教育,对护士进行滴速的交代等。治疗26 d后,患者病情稳定出院。
1例89歲女性患者,因間斷咳嗽、咳痰、胸悶、氣喘10年,加重5 d入院,診斷為慢性阻塞性肺疾病急性加重期、慢性肺源性心髒病、慢性Ⅱ型呼吸衰竭等。入院後先後給予頭孢他啶、頭孢哌酮舒巴坦鈉、亞胺培南西司他丁鈉、替攷拉寧、氟康唑、哌拉西林他唑巴坦抗感染;多索茶堿靜滴聯閤異丙託溴銨、佈地奈德霧化吸入平喘;氨溴索註射液祛痰;利尿劑改善心功能等治療。治療期間,結閤患者的病情及相關檢查,建議使用亞胺培南西司他丁鈉和替攷拉寧,併調整替攷拉寧及利尿藥的用量,重點鑑測頭孢哌酮舒巴坦鈉、亞胺培南西司他丁鈉、替攷拉寧的不良反應,定期鑑測血電解質,對患者進行用藥教育,對護士進行滴速的交代等。治療26 d後,患者病情穩定齣院。
1례89세녀성환자,인간단해수、해담、흉민、기천10년,가중5 d입원,진단위만성조새성폐질병급성가중기、만성폐원성심장병、만성Ⅱ형호흡쇠갈등。입원후선후급여두포타정、두포고동서파탄납、아알배남서사타정납、체고랍저、불강서、고랍서림타서파탄항감염;다색다감정적연합이병탁추안、포지내덕무화흡입평천;안추색주사액거담;이뇨제개선심공능등치료。치료기간,결합환자적병정급상관검사,건의사용아알배남서사타정납화체고랍저,병조정체고랍저급이뇨약적용량,중점감측두포고동서파탄납、아알배남서사타정납、체고랍저적불량반응,정기감측혈전해질,대환자진행용약교육,대호사진행적속적교대등。치료26 d후,환자병정은정출원。
One 89-year-old female patient was admitted to hospital mainly because of cough, phlegm, chest tightness, wheezing for 10 years and aggravation for 5 days. Clinical diagnosis was acute exacerbation of chronic obstructive pulmonary diseases, chronic pulmonary heart diseases, typeⅡrespiratory failure, etc. After hospitalization, the patient received the anti-infection therapy with ceftazidime, cefoperazone and sulbactam sodium, imipenem and cilastatin sodium, teicoplanin, lfuconazole, piperacillin and tazobactam in succession;antiasthmatic therapy with doxofylline, ipratropium bromide, budesonide;expelling phlegm therapy with ambroxol;improving heart function therapy with diuretic. During the treatment, clinical pharmacist suggested using imipenem and cilastatin sodium as well as teicoplanin, adjusted the dose of teicoplanin and diuretic, monitored the adverse drug reactions of cefoperazone and sulbactam sodium, imipenem and cilastatin sodium as well as teicoplanin, regularly detected the changes of blood electrolyte, provided medication education to the patient, helped nurses to control drop speed. The patient was in a stable condition and discharged at 26th day.